Zelan Hu Selected Research

Protein Isoforms (Isoforms)

8/2014	Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
1/2014	Knockdown of protein tyrosine phosphatase receptor U inhibits growth and motility of gastric cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zelan Hu Research Topics

Disease

2	Glioma (Gliomas) 08/2014 - 03/2013
2	Neoplasms (Cancer) 08/2014 - 01/2014
1	Premature Aging 01/2021
1	Lactose Intolerance (Intolerance, Lactose) 01/2019
1	Infections 12/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Body Weight (Weight, Body) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Inflammation (Inflammations) 03/2009
1	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2009

Drug/Important Bio-Agent (IBA)

2	Protein Tyrosine PhosphatasesIBA 08/2014 - 01/2014
2	CateninsIBA 08/2014 - 01/2014
2	Small Interfering RNA (siRNA)IBA 08/2014 - 01/2014
2	Protein Isoforms (Isoforms)IBA 08/2014 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 08/2014 - 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	LactaseIBA 01/2019
1	OsteopontinIBA 12/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2014
1	Tyrosine (L-Tyrosine)FDA Link 08/2014
1	ZincIBA 03/2009
1	Erythropoietin FDA Link 03/2009

Therapy/Procedure

1	Gastrectomy 01/2018
1	Bariatric Surgery 01/2018
1	Therapeutics 03/2013